Retension Pharmaceuticals ($RTSN) Insider Trading & Smart Money Activity

Retension Pharmaceuticals, Inc. · Biotechnology · Latest filing Oct 13, 2026

Retension Pharmaceuticals, Inc. ($RTSN) has 2 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($369.60K) and no insider sold, net +$369.60K.

Insider buyers (12 mo)
2
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$369.60K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

RTSN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 2 · $369.60K 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All RTSN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Keller Eric L.CHIEF EXECUTIVE OFFICER Buy (Open-market buy) 20.80K sh $249.60K Read
Insider Berger Franklin MDirector Buy (Open-market buy) 10K sh $120K Read

1W / 1M / 6M = how RTSN moved from the trade or filing date.

Insider trading in RTSN: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Keller Eric L. CHIEF EXECUTIVE OFFICER 1 +$249.60K Oct 13, 2026
Berger Franklin M Director 1 +$120K Oct 13, 2026

Frequently asked questions

Are RTSN insiders buying or selling?

Over the last 12 months 2 insiders made 2 open-market purchases worth $369.60K and 0 insiders made 0 open-market sales worth $0, a net +$369.60K.

What is the latest insider trade in RTSN?

Keller Eric L., CHIEF EXECUTIVE OFFICER filed a buy (open-market buy) of 20.80K sh worth $249.60K on Oct 13, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text